Readministration of gene therapy improves vision in three patients with LCA

Gene therapy for congenital blindness has taken another step forward, as researchers further improved vision in three adult patients previously treated in one eye.

ECMO Centers and Mortality From Influenza A(H1N1) [Letters]

To the Editor: Dr Noah and colleagues found that the mortality rate was lower among patients with severe suspected or confirmed 2009 influenza A(H1N1) and acute respiratory distress syndrome (ARDS) who were transferred to 4 specialized centers in the United Kingdom for treatment with extracorporeal membrane oxygenation (ECMO) compared with matched critically ill patients who were not transferred.

Sanofi profit faces 15 percent hit from cheap drug copies

PARIS (Reuters) - French drugmaker Sanofi said on Wednesday that its earnings could drop by up to 15 percent this year as top-selling drugs previously protected by patents are hit by competition from cheap copies. Sanofi expects to return to growth in subsequent years, driven by emerging markets, diabetes, vaccines, animal health, its takeover of biotechnology company Genzyme and new products ...

NanoViricides Inc. Submits Pre-IND Briefing Document for its Anti-Influenza drug, FluCide™, to the US FDA

NanoViricides, Inc. announced today that it has submitted a pre-IND briefing document to the US FDA. This submission provides the required information for the Company’s highly effective anti-influenza drug candidate, FluCide™, in support of a pre-IND Meeting.

Sanofi profit faces 15% hit from cheap drug copies

PARIS (Reuters) - French drugmaker Sanofi said on Wednesday that its earnings could drop by up to 15 percent this year as top-selling drugs previously protected by patents are hit by competition from cheap copies. Sanofi expects to return to growth in subsequent years, driven by emerging markets, diabetes, vaccines, animal health, its takeover of biotechnology company Genzyme and new products ...